AI-based medical company AIDOT (CEO Jeon Jae-hoon, formerly Buzzpoll) announced on the 27th that it has agreed to conduct a joint project with SNET System China (SNET/BEIJING) to launch Gynocular-Cerviray (Chinese name: 宫宝安), an AI-based remote cervical cancer screening system, nationwide in China.
Established in December 2012, SNET System China provides total IT solutions based on network products in China. Having achieved consistent growth each year, SNET System China plans to diversify its business to maximize revenue and actively enter the local market with online sales of business facilities, environmental equipment solutions, and medical ICT solutions.
Therefore, this contract signing and ordering ceremony is the culmination of AIDOT's extensive experience in China, optimized through trial and error, and represents the first successful overseas expansion of Korean AI medical ICT technology. In particular, Sweden's GYNIUS, which signed an exclusive contract with AIDOT last month for a cervical cancer camera (colposcope), announced its commitment to providing full technical support to SNET Systems' Chinese subsidiary for its commercialization in China.
AIDOT CEO Jeong Jae-hoon stated, "This agreement with SNET Systems' Chinese subsidiary will enable the full-scale distribution of Gynocular-Cerviray to Chinese women's hospitals and obstetrics and gynecology clinics. This agreement goes beyond simply providing a solution. It also guarantees commission revenue from screenings through platform business. This marks the beginning of a mutually beneficial business partnership with Professor Song Jae-yoon's team in the Department of Obstetrics and Gynecology at Korea University Anam Hospital, with whom we have been actively engaged through joint research, and with the Korea University Industry-Academic Cooperation Foundation, through a practical expansion into China."
CEO Jeong continued, "Based on our business in China, the largest cervical cancer screening market, we are actively discussing aggressive joint development with S-Net Systems China, a Chinese subsidiary, in the Southeast Asian market. This swift action will provide an opportunity for Korea's advanced AI technology to gain recognition overseas." He continued, "While it's undeniable that Korea's AI technology lags behind advanced countries, if supported by the superior technical skills of Korean medical professionals and AI services trained with differentiated medical big data, we can establish ourselves as a globally recognized leader."
Meanwhile, AIDOT announced plans to target the global elderly care market through its business lines, including China, by adding "NAO DETECTION AI," an AI carotid ultrasound solution currently undergoing clinical validation.
2020.04.27 10:33 / Artificial Intelligence Newspaper / Reporter Jeong Han-young
